Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

[Serotonin dysfunctions in the background of the seven deadly sins].

Janka Z.

Ideggyogy Sz. 2003 Nov 20;56(11-12):376-85. Review. Hungarian.

PMID:
14743592
2.

[Neurobiology and pharmacotherapy of social phobia].

Aouizerate B, Martin-Guehl C, Tignol J.

Encephale. 2004 Jul-Aug;30(4):301-13. Review. French.

PMID:
15538306
3.

5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis.

de Boer SF, Koolhaas JM.

Eur J Pharmacol. 2005 Dec 5;526(1-3):125-39. Epub 2005 Nov 28. Review.

PMID:
16310183
4.

Galanin receptor antagonists : a potential novel pharmacological treatment for mood disorders.

Ogren SO, Kuteeva E, Hökfelt T, Kehr J.

CNS Drugs. 2006;20(8):633-54. Review.

PMID:
16863269
5.

[Implication of genes of the serotonergic system on vulnerability to suicidal behavior].

Courtet P, Jollant F, Castelnau D, Astruc B, Buresi C, Malafosse A.

J Psychiatry Neurosci. 2004 Sep;29(5):350-9. Review. French.

6.

The developmental role of serotonin: news from mouse molecular genetics.

Gaspar P, Cases O, Maroteaux L.

Nat Rev Neurosci. 2003 Dec;4(12):1002-12. Review.

9.

Modulation of cholinergic functions by serotonin and possible implications in memory: general data and focus on 5-HT(1A) receptors of the medial septum.

Jeltsch-David H, Koenig J, Cassel JC.

Behav Brain Res. 2008 Dec 16;195(1):86-97. doi: 10.1016/j.bbr.2008.02.037. Epub 2008 Mar 4. Review.

PMID:
18400315
10.

The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression.

Müller N, Schwarz MJ.

Mol Psychiatry. 2007 Nov;12(11):988-1000. Epub 2007 Apr 24. Review.

PMID:
17457312
12.

Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice.

Deltheil T, Guiard BP, Cerdan J, David DJ, Tanaka KF, Repérant C, Guilloux JP, Coudoré F, Hen R, Gardier AM.

Neuropharmacology. 2008 Nov;55(6):1006-14. doi: 10.1016/j.neuropharm.2008.08.001. Epub 2008 Aug 12. Review.

PMID:
18761360
13.

From genes to aggressive behavior: the role of serotonergic system.

Popova NK.

Bioessays. 2006 May;28(5):495-503. Review.

PMID:
16615082
14.

A-to-I editing of the 5HT2C receptor and behaviour.

Gardiner K, Du Y.

Brief Funct Genomic Proteomic. 2006 Mar;5(1):37-42. Epub 2006 Feb 20. Review.

PMID:
16769676
15.

Suicidal behavior: relationship between phenotype and serotonergic genotype.

Courtet P, Jollant F, Castelnau D, Buresi C, Malafosse A.

Am J Med Genet C Semin Med Genet. 2005 Feb 15;133C(1):25-33. Review.

PMID:
15645480
16.

[Biological basis of anxiety disorders and serotonergic anxiolytics].

Inoue T, Izumi T, Li XB, Huang JZ, Kitaichi Y, Nakagawa S, Koyama T.

Nihon Shinkei Seishin Yakurigaku Zasshi. 2004 Jun;24(3):125-31. Review. Japanese.

PMID:
15291241
17.

Serotonin and aggressive behavior in rodents and nonhuman primates: predispositions and plasticity.

Ferrari PF, Palanza P, Parmigiani S, de Almeida RM, Miczek KA.

Eur J Pharmacol. 2005 Dec 5;526(1-3):259-73. Epub 2005 Nov 10. Review. Erratum in: Eur J Pharmacol. 2006 Mar 18;534(1-3):284-5.

PMID:
16289029
18.

Serotonin and brain development.

Sodhi MS, Sanders-Bush E.

Int Rev Neurobiol. 2004;59:111-74. Review.

PMID:
15006487
19.

The serotonergic system and anxiety.

Gordon JA, Hen R.

Neuromolecular Med. 2004;5(1):27-40. Review.

PMID:
15001810
20.

Genetics of suicide.

Bondy B, Buettner A, Zill P.

Mol Psychiatry. 2006 Apr;11(4):336-51. Review.

PMID:
16462816

Supplemental Content

Support Center